Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global human growth hormone injection market size is calculated at USD 4.82 billion in 2026 and is expected to reach around USD 8.54 billion by 2035, ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Children with growth disturbance could be offered a new weekly treatment as an alternative to daily injections. The National Institute for Health and Care Excellence (NICE) has recommended somatrogon ...

Genotropin (somatropin) is a brand-name injectable solution used for growth problems in certain adults and children. As with other drugs, Genotropin can cause side effects, such as injection site ...

AKRON, Ohio – Transgender and nonbinary patients at Summa Health’s Pride Clinic who are undergoing gender-affirming hormone therapy will have access to free injection kits thanks to an Akron Community ...

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

Five people appear to have developed Alzheimer’s disease after receiving growth hormones from deceased donors’ brains as children. Although based on a small group of people, this suggests that the ...

Every man desires to have a perfectly sculpted figure. When men see their six-pack abs, bulging biceps, and perfectly formed calves reflected in the mirror, they cannot help but feel better about ...

Lionel Messi was diagnosed with growth hormone deficiency when he was 11. The condition can affect both children and adults.

TORONTO, Jan 24 (Reuters) - Cangene Corp said on Thursday that the U.S. Food and Drug Administration has approved its Accretropin recombinant human growth hormone injection. The company also said that ...